logo-loader
viewG Medical Innovations Holdings Ltd

G Medical Innovations granted trading halt pending US purchase order update

The company is well positioned for growth in 2019 with catalysts including first production from its China facility.

Prizma mobile medical monitor
Prizma mobile medical monitor

G Medical Innovations Holdings Ltd (ASX:GMV) has been granted a trading halt by the ASX pending an announcement in respect of the receipt of material purchase orders for the supply of products into the US territory.

The halt will remain in place until the earlier of the start of trading on Thursday, January 31, or an announcement is released to market.

READ: G Medical Innovations Holdings Ltd on track for revenue growth in 2019

G Medical is well positioned for growth in 2019 with catalysts including first production from its facility in China and increased sales revenue from an expanding global presence.

The mobile and e-health company has received all formal certifications from regulatory bodies to utilise its Guangzhou facility in China for production.

Device production is expected to begin this quarter once all final device componentry has been received for the production line.

This facility will produce the company’s Prizma mobile medical monitor and the G Medical Patch (GMP) products.

Quick facts: G Medical Innovations Holdings Ltd

Price: 0.11 AUD

ASX:GMV
Market: ASX
Market Cap: $44.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 16/10/18

2 min read